References
- KongsaengdaoSManeetonBManeetonNQuality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective studyNeuropsychiat Dis Treat201713127132
- JagotaPKaewwilaiLBoonrodNImpact of neu-botulinum-toxinA on the severity and quality of life of cervical dystonia patientsTremor Other Hyperkinet Move20166407
- JankovicJTreatment of dystoniaLancet Neurol200651086487216987733
- ComellaCLThompsonPDTreatment of cervical dystonia with botulinum toxinsEur J Neurol200613Suppl 1162016417593
- ChanJBrinMFFahnSIdiopathic cervical dystonia: clinical characteristicsMov Disord1991621191262057004
- de Carvalho AguiarPMOzeliusLJClassification and genetics of dystoniaLancet Neurol20021531632512849429
- BressmanSBGreenePEDystoniaCurr Treat Options Neurol20002327528511096754
- Epidemiological Study of Dystonia in Europe Collaborative GroupA prevalence study of primary dystonia in eight European countriesJ Neurol20002471078779211127535
- SlawekJFriedmanAPotulskaAFactors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injectionsFunct Neurol20072229510017637212
- CostaJEspirito-SantoCBorgesAFerreiraJJCoelhoMSampaioCBotulinum toxin type A versus anticholinergics for cervical dystoniaCochrane Database Syst Rev20051CD004312
- WalkerFOBotulinum toxin therapy for cervical dystoniaPhys Med Rehabili Clin N Am2003144749766vi
- SimpsonDMBlitzerABrashearAAssessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyNeurology200870191699170618458230
- FerreiraJJCostaJCoelhoMSampaioCThe management of cervical dystoniaExpert Opin Pharmacother20078212914017257084
- BrashearAThe botulinum toxins in the treatment of cervical dystoniaSem Neurol20012118590
- CanoSJHobartJCEdwardsMCDIP-58 can measure the impact of botulinum toxin treatment in cervical dystoniaNeurology200667122230223217190951
- BransJWLindeboomRAramidehMSpeelmanJDLong-term effect of botulinum toxin on impairment and functional health in cervical dystoniaNeurology1998505146114639596007
- PekmezovicTSvetelMIvanovicNQuality of life in patients with focal dystoniaClin Neurol Neurosurg2009111216116418995953
- HakkinenAYlinenJRinta-KeturiMTalvitieUKautiainenHRissanenADecreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injectionsArch Phy Med Rehab2004851016841688
- HilkerRSchischniaschviliMGhaemiMJacobsARudolfJHealth related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystoniaJ Neurol Neurosurg Psychiatry200171219319911459891
- WenzelTSchniderPWimmerASteinhoffNMoraruEAuffEPsychiatric comorbidity in patients with spasmodic torticollisJ Psychosom Res19984466876909678750
- AlbaneseAAsmusFBhatiaKPEFNS guidelines on diagnosis and treatment of primary dystoniasEur J Neurol201118151820482602
- AlbaneseABarnesMPBhatiaKPA systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task ForceEur J Neurol200613543344416722965
- PoungvarinNViriyavejakulABotulinum A toxin treatment in spasmodic torticollis: report of 56 patientsJ Med Assoc Thai19947794644707706965
- BhidayasiriRTreatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responsesParkinsonism Relat Disord201117Suppl 1S20S2421999891
- HefterHBeneckeRErbguthFJostWReichelGWisselJAn open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)BMJ Open201334e001853
- SkogseidIMMaltUFRoislienJKertyEDeterminants and status of quality of life after long-term botulinum toxin therapy for cervical dystoniaEur J Nurol2007141011291137
- MordinMMasaquelCAbbottCCopley-MerrimanCFactors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinum toxin A (Dysport): results from a randomised, double-blind, placebo-controlled studyBMJ Open2014410e005150
- RadloffLSA self-report depression scale for research in the general populationAppl Psychol Meas19771385401
- BlankKGrumanCRobisonJTCase-finding for depression in elderly people: balancing ease of administration with validity in varied treatment settingsJ Gerontol A Biol Sci Med Sci200459437838415071082
- TrangkasombatULikanapichitkulDThe Children’s Depression Inventory as a screen for depression in Thai childrenJ Med Assoc Thai19978084914999277081